Skip to main content
Log in

Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria

  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Adiponectin appears to be an important modulator for metabolic and vascular diseases. A case-controlled study was designed to measure plasma adiponectin levels and investigate the effects of rosiglitazone on adiponectin levels in type 2 diabetic patients with proteinuria. Sixty-four patients (mean age, 46.1±4.6 yr; 30 male, 34 female) and 26 healthy volunteers (mean age, 45.3±4.8 yr; 14 male, 12 female) were included. Patients with proteinuria were treated with 4-mg/d rosiglitazone (n = 21, 10 males, 11 females) for 4 wk. Adiponectin levels in patients were significantly lower than those of controls (p<0.001). There were significant negative correlations between adiponectin concentrations and insulin levels as well as homeostasis model assessment (HOMA) index in patient’s group (r=−0.538, p<0.001; r,=−0.393, p=0.001, respectively). There was also a significant negative correlation between plasma adiponectin concentrations and the degree of proteinuria (r=−0.526, p=0.002). Plasma adiponectin levels in patients with proteinuria ?(n=31; 3.91±2.57 µg/mL) were significantly lower than those without proteinuria (n=33; 10.15±1.97 µg/mL) (p<0.001). After the treatment period, adiponectin levels significantly increased (p<0.001) and proteinuria, plasma insulin, and HOMA indexes significantly decreased in treatment group (p<0.001, p<0.001, p<0.001, respectively). The results suggest that adiponectin is inversely correlated with proteinuria and treatment with peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist rosiglitazone both corrects proteinuria and increases the low adiponectin levels in diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cooper, M. E. (1998). Lancet 352, 213–219.

    Article  PubMed  CAS  Google Scholar 

  2. Vlassara, H. (1996). Kidney Int. 49, 1795–1804.

    Article  PubMed  CAS  Google Scholar 

  3. Remuzzi, G. and Bertani, T. (1998). N. Engl. J. Med. 339, 1448–1456.

    Article  PubMed  CAS  Google Scholar 

  4. Lebovitz, H. E. and Banerji, M. A. (2004). Eur. J. Pharmacol. 490, 135–146.

    Article  PubMed  CAS  Google Scholar 

  5. Imano, E., Kanda, T., Nakatani, Y., et al. (1998). Diabetes Care 21(12), 2135–2139.

    Article  PubMed  CAS  Google Scholar 

  6. Nakamura, T., Ushiyama, C., Suzuki, S., et al. (2001). Diabet. Med. 18(4), 308–313.

    Article  PubMed  CAS  Google Scholar 

  7. Nicholas, S. B., Kawano, Y., Wakino, S., Collins, A. R., and Hsueh, W. A. (2001). Hypertension 37, 722–727.

    PubMed  CAS  Google Scholar 

  8. Szalkowski, D., White-Carrington, S., Berger, J., and Shang, B. (1995). Endocrinology 136, 1474–1481.

    Article  PubMed  CAS  Google Scholar 

  9. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., and Matsubara, K. (1996). Biochem. Biophys. Res. Commun. 221(2), 286–289.

    Article  PubMed  CAS  Google Scholar 

  10. Arita, Y., Kihara, S., Ouchi, N., et al. (1999). Biochem. Biophys. Res. Commun. 257, 79–83.

    Article  PubMed  CAS  Google Scholar 

  11. Ouchi, N., Kihara, S., Arita, Y., et al. (1999). Circulation 100, 2473–2476.

    PubMed  CAS  Google Scholar 

  12. Hotta, K., Funahashi, T., Arita, Y., et al. (2000). Arterioscler. Thromb. Vasc. Biol. 20, 1595–1599.

    PubMed  CAS  Google Scholar 

  13. Shimabukuro, M., Higa, N., Asahi, T., et al. (2003). J. Clin. Endocrinol. Metab. 88(7), 3236–3240.

    Article  PubMed  CAS  Google Scholar 

  14. Ouchi, N., Kihara, S., Arita, Y., et al. (2001). Circulation 103, 1057–1063.

    PubMed  CAS  Google Scholar 

  15. Ouchi, N., Ohishi, M., Kihara, S., et al. (2003). Hypertension 42(3), 231–234.

    Article  PubMed  CAS  Google Scholar 

  16. Maeda, N., Takahashi, M., Funahashi, T., et al. (2001). Diabetes 50(9), 2094–2099.

    Article  PubMed  CAS  Google Scholar 

  17. Hirose, H., Kawai, T., Yamamoto, Y., et al. (2002). Metabolism 51(3), 314–317.

    Article  PubMed  CAS  Google Scholar 

  18. Yang, W. S., Jeng, C. Y., Wu, T. J., et al. (2002). Diabetes Care 25(2), 376–380.

    Article  PubMed  CAS  Google Scholar 

  19. Koshimura, J., Fujita, H., Narita, T., et al. (2004). Biochem. Biophys. Res. Commun. 316(1), 165–169.

    Article  PubMed  CAS  Google Scholar 

  20. Zoccali, C., Mallamaci, F., Panuccio, V., et al. (2003). Kidney Int. Suppl. 84, S98-S102.

    Article  PubMed  CAS  Google Scholar 

  21. Guan, Y. and Breyer, M. D. (2001). Kidney Int. 60, 14–30.

    Article  PubMed  CAS  Google Scholar 

  22. Herrmann, S. M., Ringel, J., Wang, J. G., Staessen, J. A., and Brand, E. (2002). Diabetes 51, 2653–2657.

    Article  PubMed  CAS  Google Scholar 

  23. Mukherjee, R., Jow, L., Croston, G. E., and Paterniti, J. R. Jr. (1997). J. Biol. Chem. 272(12), 8071–8076.

    Article  PubMed  CAS  Google Scholar 

  24. Gurnell, M., Savage, D. B., Chatterjee, V. K., and O’Rahilly, S. (2003). J. Clin. Endocrinol. Metab. 88, 2412–2421.

    Article  PubMed  CAS  Google Scholar 

  25. Lebovitz, H. E. (2002). Am. J. Cardiol. 90(5A), 34G-41G.

    Article  PubMed  CAS  Google Scholar 

  26. Ouchi, N., Kihara, S., Funahashi, T., Matsuzawa, Y., and Walsh, K. (2003). Curr. Opin. Lipidol. 14(6), 561–566.

    Article  PubMed  CAS  Google Scholar 

  27. Zoccali, C., Mallamaci, F., Tripepi, G., et al. (2002). J. Am. Soc. Nephrol. 13(1), 13–141.

    Article  Google Scholar 

  28. Ruggenenti, P., Perna, A., Mosconi, L., Pisoni, R., and Remuzzi, G. (1998). Kidney Int. 53, 1209–1216.

    Article  PubMed  CAS  Google Scholar 

  29. Paisley, K. E., Beaman, M., Tooke, J. E., Mohamed-Ali, V., Lowe, G. D., and Shore, A. C. (2003). Kidney Int. 63, 624–633.

    Article  PubMed  Google Scholar 

  30. Maeda, N., Takahashi, M., Funahashi, T., et al. (2001). Diabetes 50, 2094–2099.

    Article  PubMed  CAS  Google Scholar 

  31. Phillips, S. A., Ciaraldi, T. P., Kong, A. P., et al. (2003). Diabetes 52(3), 667–674.

    Article  PubMed  CAS  Google Scholar 

  32. Faraj, M., Havel, P. J., Phelis, S., Blank, D., Sniderman, A. D., and Cianflone, K. (2003). J. Clin. Endocrinol. Metab. 88(4), 1594–1602.

    Article  PubMed  CAS  Google Scholar 

  33. Combs, T. P., Wagner, J. A., Berger, J., et al. (2002). Endocrinology 143(3), 998–1007.

    Article  PubMed  CAS  Google Scholar 

  34. Pajvani, U. B., Hawkins, M., Combs, T. P., et al. (2004). J. Biol. Chem. 279(13), 12152–12162.

    Article  PubMed  CAS  Google Scholar 

  35. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., and Turner, R. C. (1985). Diabetologia 28, 412–419.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mahmut Ilker Yilmaz MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yilmaz, M.I., Sonmez, A., Caglar, K. et al. Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria. Endocr 25, 207–214 (2004). https://doi.org/10.1385/ENDO:25:3:207

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:25:3:207

Key Words

Navigation